Dance Biopharm is a privately-held company focused on the clinical development of inhaled insulin products to treat diabetes patients worldwide.
Location: United States
Member count: 11-50
Total raised: $30M
Founded date: 2009
Investors 1
Date | Name | Website |
- | Hercules C... | htgc.com |
Funding Rounds 2
Date | Series | Amount | Investors | Deal News |
23.04.2019 | - | $20.5M | - | finsmes.co... |
18.02.2015 | - | $9.5M | - | finsmes.co... |
Mentions in press and media 7
Date | Title | Description | Source |
29.05.2019 | How One Patient-Entrepreneur Is Impacting 100M Patients Worl... | Healthtech Stories highlights the unique and inspiring journeys of people driven to solve healthcare... | forbes.com... |
23.04.2019 | Dance Biopharm Holdings Completes $20.5M Financing Round | Dance Biopharm Holdings, Inc., a San Francisco, CA-based clinical stage biopharma company focused on... | finsmes.co... |
18.02.2015 | Dance Biopharm Completes $9.5M Financing | Dance Biopharm Inc., a Brisbane, CA-based biotechnology company focused on the development of inhale... | finsmes.co... |
30.12.2014 | Maker of inhalable insulin marches on in wake of scrapped IP... | This isn’t the first time a company’s attempted an airborne diabetes med – yet there’s currently a h... | medcitynew... |
13.08.2013 | From inhalable insulin to vaccines: 5 diabetes companies to ... | Then there’s Pepex Biomedical, which is developing a line of all-in-one blood glucose meters that us... | medcitynew... |
- | Maker of inhalable insulin marches on in wake of scrapped IP... | It’s a drug meant for the injection-weary diabetic set: Dance Biopharm‘s developing an inhalable for... | medcitynew... |
- | From inhalable insulin to vaccines: 5 diabetes companies to ... | With an estimated 370 million people expected to have diabetes by 2030, the already $41 million mark... | medcitynew... |